UCB SA (UCBJF)

OTCMKTS · Delayed Price · Currency is USD

278.11

-33.73 (-10.82%)

At close: Mar 6, 2026

UCB SA Employees

UCB SA had 9,765 employees as of December 31, 2025. The number of employees increased by 713 or 7.88% compared to the previous year.

Employees

9,765

Change (1Y)

713

Growth (1Y)

7.88%

Revenue / Employee

$930,761

Profits / Employee

$187,331

Market Cap

55.42B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2025	9,765	713	7.88%
Dec 31, 2024	9,052	-31	-0.34%
Dec 31, 2023	9,083	380	4.37%
Dec 31, 2022	8,703	142	1.66%
Dec 31, 2021	8,561	190	2.27%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Related Stocks

Company Name	Employees
Northwest Biotherapeutics	25
CytoDyn	13
Silence Therapeutics	116
Vaxart	105
Nuo Therapeutics	9
Vicapsys Life Sciences	2
Cell Source	1
ZIVO Bioscience	7

Employee Rankings

UCB SA News

5 days ago - Belgium's UCB in autoimmune drug deal with Antengene - Reuters
4 months ago - U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d) - PRNewsWire